Stress testing with closed-loop arbutamine as an alternative to exercise

Charles A. Dennis, Peter E. Pool, Edward J. Perrins, Syed M. Mohiuddin, Joel Sklar, William J. Kostuk, David W M Muller, Mark R. Starling

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objectives.: This study compared exercise and pharmacologic stress testing using arbutamine delivered by a closed-loop device for the detection of coronary artery disease. Background.: Arbutamine, an agent designed to simulate exercise, has been developed in conjunction with a closed-loop delivery device that modulates the rate of administration on the basis of physiologic feedback. Methods.: Two hundred ten patients (180 men, 30 women) with symptoms and angiographic evidence of coronary artery disease were studied. Ischemia was categorized in three ways: 1) the presence of angina; 2) the occurrence of ≥0.1-mV horizontal or downsloping ST segment depression or elevation at 60 ms after the J point; or 3) the presence of either condition 1 or 2. Results.: In the 210 patients, the mean increase in heart rate and systolic blood pressure evoked by arbutamine and exercise was 51 and 53 beats/min (p = NS) and 36 and 44 mm Hg (p <0.0001), respectively. Arbutamine detected ischemia more often than exercise with each of the three ischemic end points. Sensitivity for detecting ischemia by either angina or ST segment change was 84% (95% confidence interval [CI] 79% to 89%) for arbutamine and 75% (95% CI 69% to 81%) for exercise testing (p = 0.014). For angina alone, sensitivity was 73% (95% CI 67% to 79%) for arbutamine and 64% (95% CI 57% to 71%) for exercise (p = 0.026). For ST segment change alone, sensitivity was 47% (95% CI 40% to 54%) for arbutamine and 44% (95% CI 37% to 51%) for exercise (p = 0.426). Cardiac events occurred in five patients (1.8%) within 24 h of the arbutamine test. Conclusions.: In detecting documented coronary artery disease, the sensitivity of arbutamine testing was equal to that of exercise for the electrocardiographic end point of ST segment change alone. Arbutamine testing was significantly superior to exercise testing for either ST change or angina or for angina alone.

Original languageEnglish
Pages (from-to)1151-1158
Number of pages8
JournalJournal of the American College of Cardiology
Volume26
Issue number5
DOIs
StatePublished - Nov 1 1995

Fingerprint

Exercise
Confidence Intervals
Coronary Artery Disease
Ischemia
arbutamine
Blood Pressure
Equipment and Supplies
Heart Rate

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Nursing(all)

Cite this

Dennis, C. A., Pool, P. E., Perrins, E. J., Mohiuddin, S. M., Sklar, J., Kostuk, W. J., ... Starling, M. R. (1995). Stress testing with closed-loop arbutamine as an alternative to exercise. Journal of the American College of Cardiology, 26(5), 1151-1158. https://doi.org/10.1016/0735-1097(95)00297-9

Stress testing with closed-loop arbutamine as an alternative to exercise. / Dennis, Charles A.; Pool, Peter E.; Perrins, Edward J.; Mohiuddin, Syed M.; Sklar, Joel; Kostuk, William J.; Muller, David W M; Starling, Mark R.

In: Journal of the American College of Cardiology, Vol. 26, No. 5, 01.11.1995, p. 1151-1158.

Research output: Contribution to journalArticle

Dennis, CA, Pool, PE, Perrins, EJ, Mohiuddin, SM, Sklar, J, Kostuk, WJ, Muller, DWM & Starling, MR 1995, 'Stress testing with closed-loop arbutamine as an alternative to exercise', Journal of the American College of Cardiology, vol. 26, no. 5, pp. 1151-1158. https://doi.org/10.1016/0735-1097(95)00297-9
Dennis, Charles A. ; Pool, Peter E. ; Perrins, Edward J. ; Mohiuddin, Syed M. ; Sklar, Joel ; Kostuk, William J. ; Muller, David W M ; Starling, Mark R. / Stress testing with closed-loop arbutamine as an alternative to exercise. In: Journal of the American College of Cardiology. 1995 ; Vol. 26, No. 5. pp. 1151-1158.
@article{a730220d95da4470b9c6f441aa0200a7,
title = "Stress testing with closed-loop arbutamine as an alternative to exercise",
abstract = "Objectives.: This study compared exercise and pharmacologic stress testing using arbutamine delivered by a closed-loop device for the detection of coronary artery disease. Background.: Arbutamine, an agent designed to simulate exercise, has been developed in conjunction with a closed-loop delivery device that modulates the rate of administration on the basis of physiologic feedback. Methods.: Two hundred ten patients (180 men, 30 women) with symptoms and angiographic evidence of coronary artery disease were studied. Ischemia was categorized in three ways: 1) the presence of angina; 2) the occurrence of ≥0.1-mV horizontal or downsloping ST segment depression or elevation at 60 ms after the J point; or 3) the presence of either condition 1 or 2. Results.: In the 210 patients, the mean increase in heart rate and systolic blood pressure evoked by arbutamine and exercise was 51 and 53 beats/min (p = NS) and 36 and 44 mm Hg (p <0.0001), respectively. Arbutamine detected ischemia more often than exercise with each of the three ischemic end points. Sensitivity for detecting ischemia by either angina or ST segment change was 84{\%} (95{\%} confidence interval [CI] 79{\%} to 89{\%}) for arbutamine and 75{\%} (95{\%} CI 69{\%} to 81{\%}) for exercise testing (p = 0.014). For angina alone, sensitivity was 73{\%} (95{\%} CI 67{\%} to 79{\%}) for arbutamine and 64{\%} (95{\%} CI 57{\%} to 71{\%}) for exercise (p = 0.026). For ST segment change alone, sensitivity was 47{\%} (95{\%} CI 40{\%} to 54{\%}) for arbutamine and 44{\%} (95{\%} CI 37{\%} to 51{\%}) for exercise (p = 0.426). Cardiac events occurred in five patients (1.8{\%}) within 24 h of the arbutamine test. Conclusions.: In detecting documented coronary artery disease, the sensitivity of arbutamine testing was equal to that of exercise for the electrocardiographic end point of ST segment change alone. Arbutamine testing was significantly superior to exercise testing for either ST change or angina or for angina alone.",
author = "Dennis, {Charles A.} and Pool, {Peter E.} and Perrins, {Edward J.} and Mohiuddin, {Syed M.} and Joel Sklar and Kostuk, {William J.} and Muller, {David W M} and Starling, {Mark R.}",
year = "1995",
month = "11",
day = "1",
doi = "10.1016/0735-1097(95)00297-9",
language = "English",
volume = "26",
pages = "1151--1158",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Stress testing with closed-loop arbutamine as an alternative to exercise

AU - Dennis, Charles A.

AU - Pool, Peter E.

AU - Perrins, Edward J.

AU - Mohiuddin, Syed M.

AU - Sklar, Joel

AU - Kostuk, William J.

AU - Muller, David W M

AU - Starling, Mark R.

PY - 1995/11/1

Y1 - 1995/11/1

N2 - Objectives.: This study compared exercise and pharmacologic stress testing using arbutamine delivered by a closed-loop device for the detection of coronary artery disease. Background.: Arbutamine, an agent designed to simulate exercise, has been developed in conjunction with a closed-loop delivery device that modulates the rate of administration on the basis of physiologic feedback. Methods.: Two hundred ten patients (180 men, 30 women) with symptoms and angiographic evidence of coronary artery disease were studied. Ischemia was categorized in three ways: 1) the presence of angina; 2) the occurrence of ≥0.1-mV horizontal or downsloping ST segment depression or elevation at 60 ms after the J point; or 3) the presence of either condition 1 or 2. Results.: In the 210 patients, the mean increase in heart rate and systolic blood pressure evoked by arbutamine and exercise was 51 and 53 beats/min (p = NS) and 36 and 44 mm Hg (p <0.0001), respectively. Arbutamine detected ischemia more often than exercise with each of the three ischemic end points. Sensitivity for detecting ischemia by either angina or ST segment change was 84% (95% confidence interval [CI] 79% to 89%) for arbutamine and 75% (95% CI 69% to 81%) for exercise testing (p = 0.014). For angina alone, sensitivity was 73% (95% CI 67% to 79%) for arbutamine and 64% (95% CI 57% to 71%) for exercise (p = 0.026). For ST segment change alone, sensitivity was 47% (95% CI 40% to 54%) for arbutamine and 44% (95% CI 37% to 51%) for exercise (p = 0.426). Cardiac events occurred in five patients (1.8%) within 24 h of the arbutamine test. Conclusions.: In detecting documented coronary artery disease, the sensitivity of arbutamine testing was equal to that of exercise for the electrocardiographic end point of ST segment change alone. Arbutamine testing was significantly superior to exercise testing for either ST change or angina or for angina alone.

AB - Objectives.: This study compared exercise and pharmacologic stress testing using arbutamine delivered by a closed-loop device for the detection of coronary artery disease. Background.: Arbutamine, an agent designed to simulate exercise, has been developed in conjunction with a closed-loop delivery device that modulates the rate of administration on the basis of physiologic feedback. Methods.: Two hundred ten patients (180 men, 30 women) with symptoms and angiographic evidence of coronary artery disease were studied. Ischemia was categorized in three ways: 1) the presence of angina; 2) the occurrence of ≥0.1-mV horizontal or downsloping ST segment depression or elevation at 60 ms after the J point; or 3) the presence of either condition 1 or 2. Results.: In the 210 patients, the mean increase in heart rate and systolic blood pressure evoked by arbutamine and exercise was 51 and 53 beats/min (p = NS) and 36 and 44 mm Hg (p <0.0001), respectively. Arbutamine detected ischemia more often than exercise with each of the three ischemic end points. Sensitivity for detecting ischemia by either angina or ST segment change was 84% (95% confidence interval [CI] 79% to 89%) for arbutamine and 75% (95% CI 69% to 81%) for exercise testing (p = 0.014). For angina alone, sensitivity was 73% (95% CI 67% to 79%) for arbutamine and 64% (95% CI 57% to 71%) for exercise (p = 0.026). For ST segment change alone, sensitivity was 47% (95% CI 40% to 54%) for arbutamine and 44% (95% CI 37% to 51%) for exercise (p = 0.426). Cardiac events occurred in five patients (1.8%) within 24 h of the arbutamine test. Conclusions.: In detecting documented coronary artery disease, the sensitivity of arbutamine testing was equal to that of exercise for the electrocardiographic end point of ST segment change alone. Arbutamine testing was significantly superior to exercise testing for either ST change or angina or for angina alone.

UR - http://www.scopus.com/inward/record.url?scp=0028858068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028858068&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(95)00297-9

DO - 10.1016/0735-1097(95)00297-9

M3 - Article

C2 - 7594026

AN - SCOPUS:0028858068

VL - 26

SP - 1151

EP - 1158

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 5

ER -